Home › Cancro colorettale › Ohio › Columbus
Studi clinici su Cancro colorettale a Columbus, OH
24 studi su Cancro colorettale cercano partecipanti presso sedi a Columbus e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
In reclutamentoFase 2
- Ohio State University Comprehensive Cancer Center, Columbus
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Ohio State University Comprehensive Cancer Center, Columbus
- Mount Carmel East Hospital, Columbus
- The Mark H Zangmeister Center, Columbus
- e altri 8
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
In reclutamentoFase 1
- ALX Center 10, Columbus
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
In reclutamentoStudio osservazionale
- The Ohio State University Comprehensive Cancer Center, Columbus
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
In reclutamentoFase 3
- Ohio State University Comprehensive Cancer Center, Columbus
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
In reclutamentoFase 2/3
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center, Columbus
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
In reclutamentoFase 2
- Research Site, Columbus
Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer
In reclutamentoFase 1
- Ohio State University Comprehensive Cancer Center, Columbus
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
In reclutamentoFase 3
- Ohio State University-Arthur G James Comprehensive Cancer Center, Columbus
- Ohio Health, Columbus
- Zangmeister Center, Columbus
Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
In reclutamentoFase 1
- Ohio State University Comprehensive Cancer Center, Columbus
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
In reclutamentoFase 1
- The Ohio State University (OSU) Wexner Medical Center, Columbus
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
In reclutamentoFase 1/2
- The Ohio State University Comprehensive Cancer Center, Columbus
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
In reclutamentoFase 1/2
- Ohio State University, Columbus
A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
In reclutamentoFase 2
- The Ohio State University Comprehensive Cancer Center, Columbus
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
In reclutamentoFase 4
- Zangmeister Cancer Center, Columbus
Lead-212 PSV359 Therapy for Patients With Solid Tumors
In reclutamentoFase 1/2
- Ohio State University, Columbus
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
In reclutamentoFase 1/2
- The Ohio State University Comprehensive Cancer Center, Columbus
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
In reclutamentoFase 1
- Ohio State University, Columbus
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
In reclutamentoFase 1/2
- Stefanie Spielman Comprehensive Breast Center, Columbus
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
In reclutamentoStudio osservazionale
- Memorial Hospital, Marysville · a 27 mi di distanza
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
In reclutamentoStudio osservazionale
- The Mark H Zangmeister Center, Columbus
The Ohio State University (OSU) SCREEN Community Program
In reclutamentoVolontari sani benvenuti
- Ohio State University Comprehensive Cancer Center, Columbus
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
In reclutamentoFase 1/2
- The Ohio State University, Columbus
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
In reclutamentoStudio osservazionale
- Ohio State University, Columbus
- OhioHealth Research Institute, Columbus
Studi su Cancro colorettale in altre città
- Houston, TX102 studi
- New York City, NY77 studi
- Nashville, TN69 studi
- Boston, MA63 studi
- Los Angeles, CA59 studi
- Arlington, VA52 studi
- St. Louis, MO50 studi
- San Antonio, TX46 studi
- Philadelphia, PA44 studi
- Grand Rapids, MI40 studi
- Baldwin Park, CA38 studi
- Seattle, WA34 studi
Altri studi a Columbus
- Cancro del polmone non a piccole cellule56 studi
- Cancro al seno39 studi
- Cancro ovarico39 studi
- Cancro (tutti i tipi)38 studi
- Cancro ai polmoni37 studi
- Leucemia mieloide acuta35 studi
- Leucemia linfatica cronica28 studi
- Cancro metastatico27 studi
- Cancro dell'endometrio25 studi
- Cancro alla prostata24 studi
- Mieloma multiplo24 studi
- Melanoma21 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.